Abstract
OBJECTIVE:
To compare the different sterility standards and the cost issues involved when choosing an opioid product for intraspinal administration.
DATA SOURCES:
Literature accessed through MEDLINE and other Internet search engines (September 2002–April 2003) was evaluated. Key search terms included epidural/intrathecal, opioids, sterility, and compounding.
DATA SYNTHESIS:
Intraspinal use is prevalent in the area of pain management. Product selection is of utmost importance when administering through the intraspinal route. An evaluation of guidelines on sterility and a cost comparison were conducted.
CONCLUSIONS:
The preservative-free commercially available products that are indicated for intrathecal/epidural use are the best alternative due to proper outside testing and stringent quality assurance. The generic morphine preservative-free product may also be considered if proper steps are taken to ensure that the final product is diluted properly.
Keywords
Get full access to this article
View all access options for this article.
